Integrase inhibitors in late pregnancy and rapid HIV viral load reduction.
about
Antiretroviral Therapy Containing Raltegravir to Prevent Mother-to-Child Transmission of HIV in Infected Pregnant WomenPharmacokinetics and Placental Transfer of Elvitegravir, Dolutegravir, and Other Antiretrovirals during Pregnancy.Safety and pharmacokinetics of dolutegravir in HIV-positive pregnant women: a systematic review.Evaluating outcomes of mother-infant pairs using dolutegravir for HIV treatment during pregnancy
P2860
Integrase inhibitors in late pregnancy and rapid HIV viral load reduction.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Integrase inhibitors in late pregnancy and rapid HIV viral load reduction.
@en
Integrase inhibitors in late pregnancy and rapid HIV viral load reduction.
@nl
type
label
Integrase inhibitors in late pregnancy and rapid HIV viral load reduction.
@en
Integrase inhibitors in late pregnancy and rapid HIV viral load reduction.
@nl
prefLabel
Integrase inhibitors in late pregnancy and rapid HIV viral load reduction.
@en
Integrase inhibitors in late pregnancy and rapid HIV viral load reduction.
@nl
P2093
P2860
P1476
Integrase inhibitors in late pregnancy and rapid HIV viral load reduction.
@en
P2093
Andrea Ciaranello
Bassam H Rimawi
Dominika Seidman
Elizabeth Livingston
Elizabeth M Stringer
Emilly S Miller
Gweneth B Lazenby
HOPES (HIV OB Pregnancy Education Study) Group
Jean R Anderson
Jenell S Coleman
P2860
P304
P356
10.1016/J.AJOG.2015.12.052
P407
P577
2016-03-01T00:00:00Z